Clinical features of childhood narcolepsy. Can cataplexy be foretold?

European Journal of Paediatric Neurology

Volumn 15, Issue 4, 2011, Pages 320-325

  Nevsimalova, Sona ^a   Jara, Cecilia ^b   Prihodova, Iva ^a   Kemlink, David ^a   Sonka, Karel ^a   Skibova, Jelena ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cataplexy; Childhood narcolepsy; Clinical features; Multiple sleep latency test; Polysomnography

Indexed keywords

HLA DQB1 ANTIGEN;

ACADEMIC ACHIEVEMENT; ADOLESCENT; AROUSAL; ARTICLE; BEHAVIOR DISORDER; BODY MASS; CATAPLEXY; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; EPWORTH SLEEPINESS SCALE; FEMALE; FISHER EXACT TEST; HLA TYPING; HUMAN; HYPNAGOGIC HALLUCINATION; MALE; NARCOLEPSY; NIGHT SLEEP; NONREM SLEEP; PARASOMNIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANK SUM TEST; REM SLEEP; SLEEP; WAKEFULNESS;

ADOLESCENT; AGE OF ONSET; CHILD; COHORT STUDIES; FEMALE; HALLUCINATIONS; HUMANS; MALE; NARCOLEPSY; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REM SLEEP PARASOMNIAS; SLEEP, REM; WAKEFULNESS;

EID: 79958817908     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2011.01.008     Document Type: Article

References (37)

1. Mignot E. Sleep, sleep disorder and hypocretin (orexin). Sleep Med 2004;5(Suppl. 1):S2-8.
2. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with T-cell receptor alpha locus. Nat Genet 2009;41:708-11.
3. Aran A, Lin L, Nevsimalova S, et al. Elevated antistreptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009;32:979-83.
4. McKenna C, McNicholas F. Childhood onset narcolepsy. A case report. Eur Child Adolesc Psychiatry 2003;12:43-7.
5. Guilleminault C, Pelayo R. Narcolepsy in prepubertal children. Ann Neurol 1998;43:135-42. (Pubitemid 28124662)
6. Ohayon MM, Priest RG, Zulley JJ, et al. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002;58:1826-33. (Pubitemid 34663586)
7. Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med 2007;8:373-99. (Pubitemid 46722263)
8. Nevsimalova S. Narcolepsy in childhood. Sleep Med Rev 2009;13:169-80.
9. International Classification of Sleep Disorders. Diagnostic and coding manual. 2nd ed. Westchester, IL, USA: American Academy of Sleep Medicine; 2005.
10. Kotagal S, Hartse KM, Walch JK. Characteristics of narcolepsy in pre-teenaged children. Pediatrics 1990;85:205-9.
11. Nevsimalova S, Prihodova I, Kemlink D, Ling L, Mignot E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med 2007;8:784-6. (Pubitemid 47535007)
12. Carskadon MA, Dement WC, Mitler M, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24. (Pubitemid 17131209)
13. Challamel MJ. Hypersomnia in children. In: Billiard M, editor. Sleep-physiology, investigation and medicine. New York: Kluwer Academic/Plenum Publishers; 2003. p. 457-68.
14. Zuberi SM.Narcolepsyinchildhood. J PediatrNeurol 2010;8:79-80.
15. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
16. Rechstchaffen A, Kales A, editors. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service - Brain Research Institute, UCLA; 1968.
17. Roth T, Roehrs TA, Rosenthal L. Measurement of sleepiness and alertness: multiple sleep latency test. In: Chokroverty S, editor. Sleep disorders medicine. Basic science, technical considerations, and clinical aspects. Boston: Butterworth Heinemann; 1999. p. 223-9.
18. Peterson PC, Husain AM. Pediatric narcolepsy. Brain Dev 2008;30:609-23.
19. Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 2006;118:1116-23.
20. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiological insight, and future perspectives. J Clin Neurophysiol 2001;18:78-105. (Pubitemid 32549906)
21. Thorphy M. Current concepts on the etiology, diagnosis and treatment of narcolepsy. Sleep Med 2001;2:5-17.
22. Nevsimalova S, Buskova J, Kemlink D, Sonka K, Skibova J. Does age at the onset of narcolepsy influence the course and severity of the disease? Sleep Med 2009;10:967-72.
23. Serra L, Montagna P, Mignot E, Lugaresi E, Plazzi G. Cataplexy features in childhood narcolepsy. Mov Disord 2008;23:858-65.
24. Sasai T, Inoue Y, Komada Y, Sugiura T, Matsushima E. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1*1501/ DRB1*0602 finding. Sleep Med 2009;10:961-6.
25. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40. (Pubitemid 30072183)
26. Wise MS. Childhood narcolepsy. Neurology 1998;50(Suppl. 1):S37-42.
27. Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med 2004;5:147-50. (Pubitemid 38351826)
28. Chabas D, Foulon C, Gonzales J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. (Pubitemid 47548277)
29. Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic functions. Front Neuroendocrinol 2003;24:141-50. (Pubitemid 37329470)
30. Russell SH, Small CJ, Dakin CL, et al. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000;12:1174-8.
31. Hallmayer J, Faraco J, Ling L, et al. Narcolepsy is strongly associated with the CR alpha locus. Nat Genet 2009;41:708-11.
32. Kawashima M, Lin L, Tanaka S, et al. Anti-Tribbles homolog 2 (TRB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010;33:869-74.
33. Lecendreux M, Maret S, Bassetti C, Mouren MC, Taffi M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old-boy. Letter to the Editor. J Sleep Res 2003;12:1-2.
34. Dauvilliers Y, Carlander B, River F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 2004;56:905-8. (Pubitemid 39578460)
35. Davilliers Y, Abril B, Mas E, Michel F, Tafti M. Normalization of hypocretin-1 narcolepsy after intravenous immunoglobin treatment. Neurology 2009;73:1333-4.
36. Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy. J Neurol 2008;255:1900-3.
37. Plazzi G, Poli F, Franceschini C, et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol 2008;255:1549-54.